Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Edouard Luyt

Showing results (1-10 of 305) with videos related to

Pageof 31
Sort By:
Intensive Care Medicine|June 23, 2006
Virus diseases in ICU patients: a long time underestimated; but be aware of overestimationCharles-Edouard Luyt
Virologie (Montrouge, France)|October 28, 2020
[Herpes simplex virus pneumonia]Charles-Edouard Luyt
American Journal of Respiratory and Critical Care Medicine|May 17, 2022
Monocyte: A New Player in the Pathophysiology of Herpes Simplex Virus Reactivation in ICU Patients?Charles-Edouard Luyt
Expert Review of Respiratory Medicine|August 28, 2023
Procalcitonin as a biomarker to guide treatments for patients with lower respiratory tract infectionsOuriel Saura, Charles-Edouard Luyt
American Journal of Respiratory and Critical Care Medicine|August 17, 2012
Virus detection in patients with severe pneumonia: still more questions than answers?Charles-Edouard Luyt, Laurent Kaiser
Intensive Care Medicine|September 21, 2016
Understanding resistanceFrançois Barbier, Charles-Edouard Luyt
Intensive Care Medicine|February 6, 2016
Does this patient have VAP?Jean Chastre, Charles-Edouard Luyt
Respiratory Care|April 19, 2011
Plasma procalcitonin: another arrow in our quiver?Charles-Edouard Luyt, Jean Chastre
Critical Care Medicine|November 18, 2017
The authors replyCharles Edouard Luyt, Laurence Dangers
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2010
Other therapeutic modalities and practices: implications for clinical trials of hospital-acquired or ventilator-associated pneumoniaJean Chastre, Charles-Edouard Luyt
Pageof 31

Showing results (1-10 of 305) with videos related to

Sort By:
Pageof 31
Intensive Care Medicine|June 23, 2006
Virus diseases in ICU patients: a long time underestimated; but be aware of overestimationCharles-Edouard Luyt
Virologie (Montrouge, France)|October 28, 2020
[Herpes simplex virus pneumonia]Charles-Edouard Luyt
American Journal of Respiratory and Critical Care Medicine|May 17, 2022
Monocyte: A New Player in the Pathophysiology of Herpes Simplex Virus Reactivation in ICU Patients?Charles-Edouard Luyt
Expert Review of Respiratory Medicine|August 28, 2023
Procalcitonin as a biomarker to guide treatments for patients with lower respiratory tract infectionsOuriel Saura, Charles-Edouard Luyt
American Journal of Respiratory and Critical Care Medicine|August 17, 2012
Virus detection in patients with severe pneumonia: still more questions than answers?Charles-Edouard Luyt, Laurent Kaiser
Intensive Care Medicine|September 21, 2016
Understanding resistanceFrançois Barbier, Charles-Edouard Luyt
Intensive Care Medicine|February 6, 2016
Does this patient have VAP?Jean Chastre, Charles-Edouard Luyt
Respiratory Care|April 19, 2011
Plasma procalcitonin: another arrow in our quiver?Charles-Edouard Luyt, Jean Chastre
Critical Care Medicine|November 18, 2017
The authors replyCharles Edouard Luyt, Laurence Dangers
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2010
Other therapeutic modalities and practices: implications for clinical trials of hospital-acquired or ventilator-associated pneumoniaJean Chastre, Charles-Edouard Luyt
Pageof 31